Compass Pathways PLC (CMPS) is the subject of a news report regarding the U.S. Food and Drug Administration (FDA). The report indicates that Acting FDA Commissioner Janet Woodcock and Acting Chief Medical Officer Patrizia Cavazzoni have been tapped for permanent roles.

The report notes that Woodcock will serve as the Commissioner, while Cavazzoni will assume the position of Chief Medical Officer. These appointments follow the resignation of FDA Commissioner Stephen Hahn in May.

The report does not mention any specific actions, filings, or business developments concerning Compass Pathways or its operations.